Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Dementia drug developer Axovant nearly doubles after IPO prices above estimates at $315M
Dementia drug developer Axovant nearly doubles after IPO prices above estimates at $315M
Dementia drug developer Axovant nearly doubles after IPO prices above estimates at $315M
Submitted by
admin
on June 12, 2015 - 9:29am
Source:
Yahoo/AP
News Tags:
Axovant
dementia
IPOs
Headline:
Dementia drug developer Axovant nearly doubles after IPO prices above estimates at $315M
Do Not Allow Advertisers to Use My Personal information
